Natural Alternatives
This article was originally published in The Tan Sheet
Executive Summary
San Marcos, Calif.-based supplement firm reports sales increase of 36% to $22.7 mil. with earnings up 50% to $852,000 in the first fiscal quarter. CEO Mark Le Doux said sales are in line with fiscal 2005 growth plans, and that Natural Alternatives is "beginning to see brand preference develop" in its contract manufacturing business. In its last earnings call, the firm maintained it will continue investments in facilities and equipment throughout the fiscal year (1"The Tan Sheet" Sept. 29, 2004, In Brief)...
You may also be interested in...
Natural Alternatives
San Marcos, Calif.-based supplement firm's net sales increased 45% to $23.3 mil. in the fiscal fourth quarter (ended June 30). For the year, net sales totalled $78.5 mil., up 40%, and income jumped to $3 mil, up 171%. Year-end results for the fiscal year included a 50% increase in private label contract manufacturing sales. Natural Alternatives "invested heavily" in facilities and equipment in fiscal 2004 and "will continue those investments in fiscal 2005," according to President Randell Weaver...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.